Clinical Trials at NRG Oncology
During the past decade, NRG Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "NRG Oncology"
#1 collaborator was "NRG Oncology" with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at NRG Oncology
According to Clinical.Site data, the most researched conditions in "NRG Oncology" are
"Recurrent Endometrial Adenocarcinoma" (1 trials), "Recurrent Endometrial Carcinoma" (1 trials), "Recurrent Endometrial Clear Cell Adenocarcinoma" (1 trials), "Recurrent Endometrial Dedifferentiated Carcinoma" (1 trials) and "Recurrent Endometrial Endometrioid Adenocarcinoma" (1 trials). Many other conditions were trialed in "NRG Oncology" in a lesser frequency.
Clinical Trials Intervention Types at NRG Oncology
Most popular intervention types in "NRG Oncology" are "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Intensity-Modulated Radiation Therapy" (1 trials), "Ipilimumab" (1 trials) and "Nivolumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at NRG Oncology
The vast majority of trials in "NRG Oncology" are
1 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at NRG Oncology
Currently, there are NaN active trials in "NRG Oncology".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in NRG Oncology,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in NRG Oncology, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".